Allspring Global Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Allspring Global Investments's LLY Position: Q1 2026 in Review
Allspring Global Investments increased its Eli Lilly (LLY) stake by 3.5% in Q1 2026, buying an estimated $11.8M and bringing the position to 347,557 shares worth $332M. The position accounts for 0.56% of the portfolio, ranked #33.
Allspring Global Investments first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $363M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Allspring Global Investments held 347,557 shares of Eli Lilly worth $332M as of Q1 2026.
- Allspring Global Investments bought 11,676 Eli Lilly shares in Q1 2026, an estimated $11.8M.
- Eli Lilly made up 0.56% of Allspring Global Investments's portfolio in Q1 2026, its #33 holding.
- Allspring Global Investments first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's Eli Lilly position peaked at $363M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.